Formulation of Monoclonal Antibody Therapies 1st Edition

Capture the forefront of biologic drug development with Formulation of Monoclonal Antibody Therapies, 1st Edition by Amal Ali Elkordy. This authoritative guide instantly engages scientists, formulators, and industry leaders seeking practical, evidence-based approaches to the design, stabilization, and delivery of monoclonal antibodies.

Discover clear, concise explanations of formulation principles—from excipient selection and protein stability to aggregation control, freeze–thaw behavior, and advanced delivery systems. Written for professionals in biopharmaceutical R&D, regulatory affairs, and academic laboratories, the book blends theoretical foundation with actionable strategies for real-world challenges in mAb development and scale-up.

Readers will appreciate in-depth discussion of analytical techniques, stability testing, and regulatory considerations that streamline product development pathways across North America, Europe, and Asia. Case studies and problem-solving insights highlight how to mitigate degradation, optimize storage conditions, and tailor formulations for parenteral and novel administration routes—making this text invaluable for both early-stage researchers and seasoned biopharma formulators.

Whether you’re developing a therapeutic candidate, preparing regulatory submissions, or teaching the next generation of scientists, this edition equips you with the practical knowledge to improve product robustness and accelerate timelines. Written in an accessible, professional tone, it balances scientific rigor with pragmatic advice.

Take the next step in monoclonal antibody innovation—add Formulation of Monoclonal Antibody Therapies, 1st Edition by Amal Ali Elkordy to your reference library today and strengthen your formulation toolkit for global biopharmaceutical development.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.